Acute hemodynamic effect of sildenafil in comparison with inhaled nitric oxide in patients receiving bosentan therapy for pulmonary arterial hypertension

被引：0
|
作者：
Galie, Nazzareno [1 ]
Michelakis, Evangelos [1 ]
Vachiery, Jean-Lue [1 ]
Vizza, Carmine Dario [1 ]
Meyer, F. J. [1 ]
Gruenig, Ekkehard [1 ]
机构：
[1] Univ Bologna, Bologna, Italy
来源：
CHEST | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：488S / 488S
页数：1
相关论文
共 50 条
  • [21] Hemodynamic effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension
    Ivy, DD
    Ziegler, JW
    Kinsella, JP
    Wiggins, JW
    Abman, SH
    CHEST, 1998, 114 (01) : 17S - 17S
  • [22] Bosentan combined with sildenafil in the treatment of COPD patients with pulmonary arterial hypertension
    Li, Ying
    Wang, Yao
    Liu, Shaohua
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (10): : 11522 - 11530
  • [23] Combination Of Sildenafil To Bosentan Therapy In Patients With Pulmonary Arterial Hypertension Associated With Congenital Heart Defects
    Beciani, E.
    Leci, E.
    Palazzini, M.
    Bachetti, C.
    Sciarra, F.
    Conficoni, E.
    Manes, A.
    Galie, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [24] Comparison of the effects of bosentan and sildenafil in the treatment of persistent pulmonary arterial hypertension in infants
    Farhangdoust, Saba
    Mehralizadeh, Semira
    Bordbar, Arash
    JOURNAL OF CLINICAL NEONATOLOGY, 2020, 9 (04) : 249 - 254
  • [25] Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension
    Leuchte, HH
    Schwaiblmair, M
    Baumgartner, RA
    Neurohr, CF
    Kolbe, T
    Behr, F
    CHEST, 2004, 125 (02) : 580 - 586
  • [26] Immediate and long-term hemodynamic and clinical effects of Sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy
    Bhatia, S
    Frantz, RP
    Severson, CJ
    Durst, LA
    McGoon, MD
    MAYO CLINIC PROCEEDINGS, 2003, 78 (10) : 1207 - 1213
  • [27] Sildenafil is a pulmonary vasodilator which augments and prolongs vasodilatation by inhaled nitric oxide in patients with pulmonary hypertension
    Lepore, JJ
    Pereira, N
    Maroo, A
    Ginns, L
    Bigatello, LM
    Dec, GW
    Rubin, R
    Zapol, WM
    Bloch, KD
    Semigran, MJ
    CIRCULATION, 1999, 100 (18) : 240 - 240
  • [28] Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
    Hoeper, M. M.
    Leuchte, H.
    Halank, M.
    Wilkens, H.
    Meyer, F. J.
    Seyfarth, H. J.
    Wensel, R.
    Ripken, F.
    Bremer, H.
    Kluge, S.
    Hoeffken, G.
    Behr, J.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (04) : 691 - 694
  • [29] Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension
    Verlinden, Nathan J.
    Benza, Raymond L.
    Raina, Amresh
    PULMONARY CIRCULATION, 2020, 10 (04)
  • [30] Hemodynamic effects of dipyridamole and inhaled nitric oxide in patients with severe pulmonary hypertension.
    Ziegler, JW
    Ivy, DD
    Kinsella, JP
    Wiggins, JW
    Abman, SH
    PEDIATRIC RESEARCH, 1996, 39 (04) : 228 - 228
12345